Ribhi Shawar of FDA: Featured Speaker at World Anti-Microbial Resistance Congress USA 2016

Dr. Ribhi Shawar currently serves as the Branch Chief at the Division of Microbiology in the Office of In vitro Diagnostic and Radiological Health (OIR) at the Center for Devices and Radiological Health (CDRH) at FDA where he specializes in the area of antimicrobial susceptibility testing and detection of resistance. Dr. Shawar has a Ph.D. in Medical Microbiology and an M.Sc. in …

Jens Eckstein of SR One: Featured Speaker at World Anti-Microbial Resistance Congress USA 2016

Dr. Eckstein, President, comes to SR One from TVM Capital where he was a Venture Partner, Entrepreneur-in-Residence and appointed CEO and President of SelectX Pharmaceuticals. Prior to that, he was a General Partner in TVMs Boston life sciences practice where he focused on earlier-stage investments. He is currently a Director of Thrasos Therapeutics, Palleon Pharma, Decibel Therapeutics, Gladius Pharmaceuticals and …

David Mantus: Featured Speaker at World Anti-Microbial Resistance Congress USA 2016

David Mantus of Arsanis: Featured Speaker at World Anti-Microbial Resistance Congress USA 2016

David Mantus, Ph.D. is Chief Development Officer at Arsanis, Inc., a clinical stage biotechnology company developing monoclonal antibodies to prevent and treat serious bacterial infections. He has more than 24 years of drug development experience, including clinical, regulatory and manufacturing successes for programs in endocrinology, central nervous disorders, and infectious disease. His work in infectious disease product development has included …

Judy Hackett of AstraZeneca: Featured Speaker at World Anti-Microbial Resistance Congress USA 2016

Judy Hackett received her Pharmacy Degree from the University of Toronto.  She subsequently completed her M.B.A. at York University.  As well she has a graduate degree in Evaluation and Outcomes from the Faculty of Medicine,  University of Toronto. She began her career working in community pharmacy and then went onto work as a payer where she developed and managed drug …